After 1st part of Stage 2 of the phase 3, we will have the data to apply for accelerated approval from USA FDA.
TGA provisional approval might come around faster than June 2025 (they know us, well).
If we get DMOAD label clarity, 2x2 dose, a 30mill USD China deal (upfront) is low. We have other levers to pull on too.
MPS could surprise. MPS/OA, MPS/OA Aus…. OA China…. LATAM and Mena….
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-171
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.005(2.08%) |
Mkt cap ! $85.73M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 25.0¢ | 23.0¢ | $132.4K | 552.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 93605 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 5156 | 2 |
View Market Depth
| Last trade - 13.52pm 14/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |